This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Parliament is calling for regulators to audit pharmaceuticalcompanies that have made misleading statements to the public about their Covid-19 vaccines. A member of the U.K. And the move comes after Moderna was chastised for the second time in five months by a U.K.
Effective management of drug patent portfolios is crucial for pharmaceuticalcompanies to maintain market exclusivity, protect revenue streams, and drive innovation. A robust patent strategy aligned with business goals is essential for maximizing value and staying competitive in the pharmaceutical landscape.
The pharmaceutical industry is heavily reliant on patents to protect intellectual property and maintain market exclusivity. However, with the increasing competition from generic and biosimilar manufacturers, patent invalidity claims have become a significant challenge for pharmaceuticalcompanies.
The AI Act substantially raises the compliance bar for pharmaceuticalcompanies using AI, particularly in high-risk applications. 2 This publication represents a critical step toward providing operational clarity and practical direction for pharmaceuticalcompanies navigating this challenging regulatory environment.
This article aims to provide a comprehensive overview of the key aspects of the regulatory framework, highlighting the requirements and challenges faced by pharmaceuticalcompanies seeking to introduce generic drugs into the Japanese market.
In this article, we will delve into the benefits of working with integrated CDMO services and explore how they can streamline the drug development and manufacturing process. The Rise of Integrated CDMOs The global biotechnology and pharmaceutical services outsourcing market size was valued at $70.48 from 2023 to 2030.
Structuring patient assistance programs as independent non-profit foundations helps pharmaceuticalcompanies reduce regulatory and legal exposure while allowing for more holistic, patient-centered support. Lastly, PAPs that are directly managed by pharmaceuticalcompanies may also struggle with public image issues.
This article explores the key metrics pharma marketing teams should prioritize to drive success. Unlike traditional consumer brands, pharmaceuticalcompanies face unique challenges on social media, including strict regulations, compliance concerns, and the need for factual accuracy.
With the rapid expansion of digital platforms, evolving patient expectations, and the increasing role of AI-driven marketing, pharmaceuticalcompanies and healthcare brands are allocating more resources to advertising in 2025. Regulatory agencies are demanding clearer disclosures and evidence-based claims in pharmaceutical promotions.
In this article, we’ll explore 10 innovative trends in pharma marketing that can set you up for success in this rapidly evolving landscape. By 2025, pharmaceuticalcompanies will need to adapt and innovate to remain competitive and effectively reach their target audiences.
Introduction In the world of pharmaceutical marketing, traditional advertising methods are evolving. While pharmaceuticalcompanies have long relied on doctors, sales representatives, and TV ads to reach patients, the modern landscape requires more personalized approaches.
The Cost of Patent Litigation But what happens when a pharmaceuticalcompany's patent is challenged by a competitor or generic manufacturer? The Cost of Patent Infringement In addition to the costs of patent litigation, pharmaceuticalcompanies must also contend with the costs of patent infringement.
Recent trends and advancements in technology, research, and collaboration are reshaping the landscape of generic drug development, leading to new opportunities and challenges for pharmaceuticalcompanies. This article delves into the future of partnerships in generic drug… Source
In this article, we’ll explore the limitations of traditional HTA; the ways AI can enhance HTA methodologies; AI applications in HTA; its integration with existing frameworks; its role in value-based pricing and real-world evidence (RWE) generation; and the limitations of AI in HTA. Haub School of Business.
In this article, we will explore the value of marketing partnerships in pharma, how they work, and why they should be an integral part of your marketing strategy. For example, a pharmaceuticalcompany may partner with a healthcare provider to run awareness campaigns about a particular condition or treatment.
Diversify your portfolio : Consider investing in a range of pharmaceuticalcompanies, including those developing generic and biosimilar medications. Diversifying your portfolio and investing in a range of pharmaceuticalcompanies can help you capitalize on these opportunities. Read the full article here: [link]
This article explores the key Pharma Marketing Challenges that define 2025—and what pharma brands must do to stay relevant, effective, and compliant. For starters, trust in pharmaceuticalcompanies remains fragile. Even large pharmaceuticalcompanies sometimes struggle to extract value from their tech stack.
This article explores the evolving role of referral marketing in pharma, unpacking its mechanics, benefits, compliance considerations, and future outlook. On the patient side, pharmaceuticalcompanies have launched ambassador and mentorship programs. And what are the tools and best practices that make it successful?
Niche healthcare advertising sponsorships are partnerships where pharmaceuticalcompanies align with highly targeted healthcare media platforms, content creators, or events to reach specific audiences—be they physicians, specialists, patients, or caregivers. This delivers educational value while keeping your brand top of mind.
In this article, we explore why that network matters more now than ever before. Unlike consumer brands, pharmaceuticalcompanies must pass content through multiple layers of medical, legal, and regulatory review. The answer often lies in the strength of a brand’s marketing network. This often delays time to market.
This article explores how to develop and optimize paid social media campaigns that drive engagement while staying compliant. Disease awareness campaigns can also reach specific patient groups based on demographics and interests, helping pharmaceuticalcompanies create more personalized outreach. In the U.S.,
Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Development Library Events Press Releases PharmaVoice 100 Nominate 2024 PV100 2023 PV100 Sign up Search Sign up Search An article from Q&A Need a DTC platform?
This article explores how Integrated Marketing Communications (IMC) drives brand cohesion, regulatory clarity, and market growth within the pharmaceutical industry. For pharmaceuticalcompanies, this means synchronizing communication across advertising, medical affairs, PR, social media, digital platforms, and sales.
This allows for streamlined regulatory processes and a reduced administration load for both pharmaceuticalcompanies and health authorities, according to the paper. Use of ePI will also benefit medicine availability in small markets, supporting a more flexible supply chain, according to the paper.
July 31st 2025 Navigating Distrust: Pharma in the Age of Social Media Miranda Schmalfuhs Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceuticalcompanies and the patients they aim to serve.
Just like a trimmed sail needs stronger winds to reach its destination, streamlined pharmaceuticalcompanies must generate more impact with fewer resources. You can explore similar trends in featured articles on Pharma Marketing Network to see how industry peers are adjusting their strategies. In-person meetings are limited.
Indian pharmaceuticalcompanies supply more than 60 per cent of global demand for vaccines and over 40 per cent of generic medicines consumed in the United States (2). Why this article? For instance, India’s role as a major supplier of COVID-19 vaccines underscored its capabilities in high-volume sterile manufacturing (4).
This article examines the various types of microorganisms commonly found in pharmaceutical production environments and explores the factors that influence their growth and survival. Therefore, its microbial “cleanliness” is critical within pharmaceuticalcompanies. Additional documents are included each month.
August 1st 2025 Navigating Distrust: Pharma in the Age of Social Media Miranda Schmalfuhs Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceuticalcompanies and the patients they aim to serve.
The Tariff Effect: Greater Supply Chain Prepares for Repercussions Nicholas Saraceno, Editor June 4th 2025 Article Potential import taxes on pharma goods entering the United States continue to have effects on the industry in more ways than one. For the latest in conference coverage, please visit pharmaceuticalcommerce.com/latest-conference.
Primary Users CDSCO regulators, Pharmaceuticalcompanies seeking approval to manufacture, import, or sell drugs and biological products in India Healthcare providers, pharma industry, legal professionals/experts, Physicians, pharmacists, and the public seeking to verify drug approvals, identify interchangeable generics, and check relevant patents.
In 2022, based upon a complaint filed by a pharmaceuticalcompany, CMS was asked to reevaluate the SSA section that establishes the J-code,” Soefje said. So, the pharmaceuticalcompanies then pushed to get their 505(b)(2) drugs declared sole source,” Soefje said. “If This went into effect in January 2022.”
Thats the promise of data-driven marketing , a strategy thats rapidly transforming how pharmaceuticalcompanies approach promotion, education, and engagement in 2025. In this article, we explore how data-driven marketing empowers pharma brands to be more precise, predictive, and effective in their outreach efforts.
From manufacturing and quality control to distribution and regulatory compliance, the stakes are high for pharmaceuticalcompanies looking to bring these life-changing treatments to market. Read the full article on how to address supply chain challenges for biosimilar products: [link]
This article dives deep into why 2025 will mark a pivotal moment for pharma marketing and how savvy brands can stay ahead. The Inflation Reduction Act and new drug pricing regulations are pushing pharmaceuticalcompanies to justify value more transparently.
For pharmaceuticalcompanies navigating strict compliance and niche targeting needs, these platforms offer an ideal solution. If you’re new to digital advertising in pharma, this featured article from Pharma Marketing Network offers additional context on healthcare-specific strategies.
This is a nightmare scenario for any pharmaceuticalcompany, and it's a reality that many face every day. Read the full article here: [link] Imagine investing years of research and development into a groundbreaking new medication, only to see it copied and sold in foreign markets without your permission.
The Tariff Effect: Greater Supply Chain Prepares for Repercussions Nicholas Saraceno, Editor June 4th 2025 Article Potential import taxes on pharma goods entering the United States continue to have effects on the industry in more ways than one.
August 1st 2025 Navigating Distrust: Pharma in the Age of Social Media Miranda Schmalfuhs Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceuticalcompanies and the patients they aim to serve.
This article explores emerging strategies, tech-driven innovations, regulatory watchpoints, and how marketers can leverage AI to optimize outcomes while building trust. According to McKinsey, 70% of pharmaceuticalcompanies now use AI in marketing workflows. So, what does the new AI marketing frontier look like?
In this article, well dive into key pharma digital marketing strategies that can help pharma brands connect with healthcare professionals (HCPs), patients, and stakeholders effectively. Why is digital marketing important for pharmaceuticalcompanies? Without the right strategy, you risk getting lost in a sea of content.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content